CompletedNot Applicable

Effects of TECAR Therapy in Lipedema Management

Turkey (Türkiye)30 participantsStarted 2024-09-01

Plain-language summary

The physicians wanted to show the efficacy of a physical therapy device, Transfer Energy Capacitive and Resistive (TECAR) therapy, in women with lipedema which is an abnormal fat buildup on both sides of lower body. They focused on lower limb circumference, pain, functional capacity, and quality of life.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patients aged 18 to 60 years * Clinical diagnosis of Stage 2 lipedema (types 1-3) * Body mass index (BMI) which is less than 35 Exclusion Criteria: * Deterioration in general condition, * Presence of open wounds or sensory deficits in the area of application, * Active infections, * Malignancy, * Autoimmune or systemic inflammatory diseases (e.g., rheumatoid arthritis or systemic lupus erythematosus), * Severe cognitive impairment, * Uncontrolled chronic systemic disease, * History of physiotherapy or regular non-steroidal anti-inflammatory drug (NSAID) use within the last six months * Concomitant lymphedema or venous insufficiency.

What they're measuring

Circumference measurements

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.

visual analogue scale (VAS)

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.

The Lower Extremity Functional Scale (LEFS)

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.

The Lymphedema Quality of Life Questionnaire for the Leg (LYMQOL-Leg)

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.

Trial details

NCT IDNCT07088315

SponsorAnkara City Hospital Bilkent

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-15

View on ClinicalTrials.gov More Lipedema trials

Plain-language summary

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Circumference measurements

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.

visual analogue scale (VAS)

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.

The Lower Extremity Functional Scale (LEFS)

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.

The Lymphedema Quality of Life Questionnaire for the Leg (LYMQOL-Leg)

Timeframe: Clinical assessments were conducted at baseline, as well as at 1 and 3 months following the treatment.